Researchers demonstrated the molecular architecture of borderline resectable pancreatic ductal adenocarcinoma (PDAC) manifests cancer dissemination of PDAC. 36 organoids isolated from primary tumor masses of PDAC patients with diverse metastatic statues were presented.
[Cellular Oncology]